Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age

JAMA

Volumn 312, Issue 8, 2014, Pages 817-824

  Leuchter, Russia Ha Vinh ^a   Gui, Laura ^a   Poncet, Antoine ^a   Hagmann, Cornelia ^b   Lodygensky, Gregory Anton ^a   Martin, Ernst ^c   Koller, Brigitte ^b   Darqué, Alexandra ^a   Bucher, Hans Ulrich ^b   Hüppi, Petra Susan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

AGE DISTRIBUTION; ARTICLE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GRAY MATTER; GRAY MATTER INJURY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; SWITZERLAND; WHITE MATTER INJURY;

BRAIN; BRAIN DISEASES; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MAGNETIC RESONANCE IMAGING; NEUROPROTECTIVE AGENTS; RECOMBINANT PROTEINS; RETINOPATHY OF PREMATURITY;

EID: 84907377126     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.9645     Document Type: Article

References (40)

1. Moore T, Hennessy EM, Myles J, et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ. 2012;345:e7961.
2. Kinney HC, Volpe JJ. Modeling the encephalopathy of prematurity in animals: the important role of translational research. Neurol Res Int. 2012;2012:295389.
3. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110-124.
4. van de Looij Y, Vasung L, Sizonenko SV, Hüppi PS. MRI of animal models of developmental disorders and translation to human imaging. Curr Opin Neurol. 2014;27(2):157-167.
5. Nguyen TM, Crowther CA, Wilkinson D, Bain E. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013;2:CD009395.
6. Juul S. Neuroprotective role of erythropoietin in neonates. J Matern Fetal Neonatal Med. 2012;25(suppl 4):105-107.
7. van de Looij Y, Chatagner A, Quairiaux C, Gruetter R, Hüppi PS, Sizonenko SV. Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. PLoS One. 2014;9(4):e95643.
8. Xiong T, Qu Y, Mu D, Ferriero D. Erythropoietin for neonatal brain injury: opportunity and challenge. Int J Dev Neurosci. 2011;29(6):583-591.
9. Brown MS, Eichorst D, Lala-Black B, Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics. 2009;124(4):e681-e687.
10. McAdams RM, McPherson RJ, Mayock DE, Juul SE. Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol. 2013;33(3):226-230.
11. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol. 2010;67(5):657-666.
12. Ohls RK, Kamath-Rayne BD, Christensen RD, et al. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics. 2014;133(6):1023-1030.
13. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics. 2008;122(2):383-391.
14. Fauchère JC, Dame C, Vonthein R, et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics. 2008;122(2):375-382.
15. Volpe JJ. The encephalopathy of prematurity - brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol. 2009;16(4):167-178.
16. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med. 2006;355(7):685-694.
17. de Bruïne FT, van den Berg-Huysmans AA, Leijser LM, et al. Clinical implications of MR imaging findings in the white matter in very preterm infants: a 2-year follow-up study. Radiology. 2011;261(3):899-906.
18. Jeon TY, Kim JH, Yoo SY, et al. Neurodevelopmental outcomes in preterm infants: comparison of infants with and without diffuse excessive high signal intensity on MR images at near-term-equivalent age. Radiology. 2012;263(2):518-526.
19. Woodward LJ, Clark CA, Bora S, Inder TE. Neonatal white matter abnormalities an important predictor of neurocognitive outcome for very preterm children. PLoS One. 2012;7(12):e51879.
20. Miller SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr. 2005;147(5):609-616. (Pubitemid 41598332)
21. Kinney HC. The encephalopathy of prematurity: one pediatric neuropathologist's perspective. Semin Pediatr Neurol. 2009;16(4):179-190.
22. Dean JM, van de Looij Y, Sizonenko SV, et al. Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol. 2011;70(5):846-856.
23. Riddle A, Dean J, Buser JR, et al. Histopathological correlates ofmagnetic resonance imaging-defined chronic perinatal white matter injury. Ann Neurol. 2011;70(3):493-507.
24. Kato S, Aoyama M, Kakita H, et al. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J Neurosci Res. 2011;89(10):1566-1574.
25. Gonzalez FF, Larpthaveesarp A, McQuillen P, et al. Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke. 2013;44(3):753-758.
26. Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury. Pediatr Res. 2013;74(6):658-667.
27. Kim YJ, Jung YW. Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain. Anat Cell Biol. 2010;43(2):140-149.
28. Kinney HC, Haynes RL, Xu G, et al. Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol. 2012;71(3):397-406.
29. Kanold PO, Shatz CJ. Subplate neurons regulate maturation of cortical inhibition and outcome of ocular dominance plasticity. Neuron. 2006;51(5):627-638. (Pubitemid 44301821)
30. Kostović I, Jovanov-Milošević N, Radoš M, et al. Perinatal and early postnatal reorganization of the subplate and related cellular compartments in the human cerebral wall as revealed by histological and MRI approaches. Brain Struct Funct. 2014;219(1):231-253.
31. Jantzie LL, Corbett CJ, Firl DJ, Robinson S. Postnatal erythropoietin mitigates impaired cerebral cortical development following subplate loss from prenatal hypoxia-ischemia [published online April 9, 2014]. Cereb Cortex. doi: 10.1093/cercor/bhu066.
32. Andiman SE, Haynes RL, Trachtenberg FL, et al. The cerebral cortex overlying periventricular leukomalacia: analysis of pyramidal neurons. Brain Pathol. 2010;20(4):803-814.
33. Nagasunder AC, Kinney HC, Blüml S, et al. Abnormal microstructure of the atrophic thalamus in preterm survivors with periventricular leukomalacia. AJNR Am J Neuroradiol. 2011;32(1):185-191.
34. Keswani SC, Bosch-Marcé M, Reed N, Fischer A, Semenza GL, Höke A. Nitric oxide prevents axonal degeneration by inducing HIF-1-dependent expression of erythropoietin. Proc Natl Acad Sci U S A. 2011;108(12):4986-4990.
35. Boardman JP, Craven C, Valappil S, et al. A common neonatal image phenotype predicts adverse neurodevelopmental outcome in children born preterm. Neuroimage. 2010;52(2):409-414.
36. Dyet LE, Kennea N, Counsell SJ, et al. Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics. 2006;118(2):536-548. (Pubitemid 46085408)
37. Ment LR, Hirtz D, Hüppi PS. Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol. 2009;8(11):1042-1055.
38. Rutherford MA, Supramaniam V, Ederies A, et al. Magnetic resonance imaging of white matter diseases of prematurity. Neuroradiology. 2010;52(6):505-521.
39. Iwata S, Nakamura T, Hizume E, et al. Qualitative brain MRI at term and cognitive outcomes at 9 years after very preterm birth. Pediatrics. 2012;129(5):e1138-e1147.
40. Voigt M, Fusch C, Olbertz D, et al. Analyse des Neugeborenenkollektivs der Bundesrepublik Deutschland. Geburtshilfe Frauenheilkd. 2006;66:956-970.